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Phanourios Tamamis1 and Georgios Archontis1
Department of Physics, University of Cyprus, PO20537, CY1678, Cyprus
E-mail: archonti@ucy.ac.cy
Compstatin is a cyclic, 13-residue peptide, which binds to the protein C3 and inhibits the activa-
tion of the complement system. To obtain a better understanding of the structural properties of
the free peptide and the relation between sequence, structure and activity, we conduct multi-ns
explicit-water simulations of three related systems. i) A native analogue of compstatin that is
acetylated at the N-terminal end (NAT), ii) the inactive single mutant Q5G (G5), and iii) the
more active double mutant V4W/H9A (W4A9). In the simulations the 5–8 region adopts a β-
turn conformation with high probability, in agreement with earlier NMR studies. The propensity
of this turn is not correlated with the activity of the three analogues. The rest of the molecules
are mostly in a random-coil state, with β-turns occasionally formed outside the region 5–8.
1 Introduction
The complement system constitutes the initial defense against foreign pathogens1. The
development of drugs controlling complement activation is of significant medical interest,
as it could treat a number of pathological conditions, including rheumatoid arthritis and
rejection of xenotransplantation2. A candidate against the unregulated activation of the
complement system is the cyclic peptide compstatin, which has the sequence Ile1-Cys2-
Val3-Val4-Gln5-Asp6-Trp7-Gly8 -His9-His10-Arg11-Cys12-Thr13-NH2 and contains the
disulfide bridge Cys2–Cys12 (see fig. 1, left panel). Earlier NMR studies of the free pep-
tide showed that the segment 5–8 adopts a predominantly type-I β-turn conformation in
solution, whereas the rest of the molecule is highly flexible3. Additional systematic muta-
tional studies determined that the two cysteines 2 and 12, Val3 and the residues 5–8 of the
β-turn are critical for activity, but the turn itself is not sufficient for activity. In contrast,
residues Val4, His9, His10 and Arg11 are not required for activity4, 5.
Apart from the formation of the 5–8 β-turn, the information from the NMR spectra
on intramolecular interactions is limited, due to extensive conformational averaging. To
gain insight on these interactions, we conduct multi-ns molecular dynamics simulations of
a native analogue (NAT) (acetylated at the N-terminal end and more active by a factor of
three), the single inactive mutant Q5G (G5)3, and the double mutant V4W/H9A (W4A9),
which has a 45-fold higher activity than the native compound4, 5.
2 Methods
The simulation methodology has been described in detail in ref.6. Briefly, the total system
consisted of one peptide and 7921 water molecules (23975 atoms in the case of NAT).
The interatomic interactions were taken from the CHARMM22 all-atom force field7 and
the water was represented by a modified TIP3P model8. All simulations employed cubic
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Figure 1. Left: Typical simulation structure of NAT. Right: Average residue secondary-structure population.
The continuous, dotted and long-dashed lines correspond, respectively, to G5, NAT and W4A9.
boundary conditions and were performed with the program CHARMM9, version c31b2.
For NAT, W4A9 and G5 we conducted, respectively, 22, 16 and 11 independent 2-ns sim-
ulations, starting from several different NMR structures (entry 1A1P3).
3 Results
To determine the average secondary structure of the three systems, we analyzed snapshots
extracted at 5-ps intervals with the algorithm STRIDE10. The left panel of fig. 1 shows
a representative simulation structure of the NAT analogue. The most important observed
secondary structural elements correspond to random coil (C), β-turn (T), β-bridge (B) and
β-sheet (E). The right panel of fig. 1 shows the corresponding average populations.
In all three analogues the region 5–8 folds into a β-turn with probability 85% (G5) to
70% (W4A9). The highest turn population corresponds to the inactive peptide (G5) and
the lowest to the more active double mutant W4A9. Thus, the 5–8 turn propensity is not
proportional to the peptide activity and its formation is not sufficient for activity, as shown
by G5. A similar observation has been made with the inactive mutant V3A, which also
has a high 5–8 turn propensity4. The probability of type I/III turns (family αR-αR12) is
36.6%–33.5% for NAT, in good agreement with the NMR estimate. In G5 and W4A9 the
probability is, respectively, higher and smaller than NAT6.
There is a small to moderate probability for the occurence of turns elsewhere in the
sequence. The most important of these is formed by the segment 6–9 in analogue W4A9,
and is usually fused with the turn 5–8. Additional β-turns do occur in segments 1–4, 2–5,
8–11 and 9–12, but with significantly lower probability6. The N-terminal (1–4) and C-
terminal (9–13) regions are largely unstructured. This is in agreement with the observed
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conformational averaging in the NMR spectra, which has demonstrated that the region
outside 5–8 is highly flexible.
Earlier MD simulations with a generalized Born approximation for the solvent11 and
a polar hydrogen energy function9 suggested the frequent formation of β-hairpin and α-
helical motifs12. In the current simulations, the 3–9 region of NAT forms a β-hairpin with
a ≈ 5% probability (fig. 1). In the other two analogues, the corresponding probability
is 1.7% (W4A9) and 1.5% (G5). The inactive (G5) analogue forms the two main chain
hydrogen bonds Val3(O)-His10(N) and Gln5(N)-Gly8(O), creating an isolated bridge be-
tween residues 4 and 9 (fig. 1). We conducted test simulations of the NAT system with the
same GB energy function9, 11, 12, in which the peptide formed β-hairpin and α-helical ele-
ments lasting for tens of ns (not shown). Such discrepancies between explicit and implicit
solvent treatments have been observed with various GB implementations13, 14, possibly due
to overstimation of the intramolecular interactions by GB. At the same time, the current
explicit solvent simulations could underestimate somewhat the formation of β-hairpin and
α-helical elements (despite their success in reproducing the NMR 5-8 β-turn population),
due to the finite length of the simulations and force-field inaccuracies.
In conclusion, our simulations suggest that the free peptides are flexible, with a
propensity for a 5–8 β-turn which is not proportional to activity and is highest for the
inactive peptide (G5). The remainder of the molecule is predominantly in a random coil
state, with additional β-turns occasionally observed outside the region 5–8.
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